Selected outcome
Before Jan 1, 2028
71%
Before Jan 1, 2028 · 71%
Stored quote · checking the venue
- Scheduled end
- Dec 31, 2026 ET
- Resolution source
- Food and Drug Administration (opens in a new tab)
Price
Loading price history.
Markets
- Before Jul 1, 2027
When will the FDA approve retatrutide (LY3437943)?
18%
Open · ~$21 24h · ~$3,323 vol
Bid 17¢ · Ask 18¢
- Before Jan 1, 2028
When will the FDA approve retatrutide (LY3437943)?
71%
Open · ~$7 24h · ~$4,362 vol
Bid 70¢ · Ask 71¢
- Before Jan 1, 2027
When will the FDA approve retatrutide (LY3437943)?
4%
Open · ~$6 24h · ~$1,788 vol
Bid 3¢ · Ask 4¢
- Before Jul 1, 2028
When will the FDA approve retatrutide (LY3437943)?
85%
Open · ~$2 24h · ~$93 vol
Bid 84¢ · Ask 85¢
- Before Jan 1, 2029
When will the FDA approve retatrutide (LY3437943)?
90%
Open · ~$0 24h · ~$144 vol
Bid 89¢ · Ask 90¢
Event statistics
How this resolves
- Scheduled end
- Dec 31, 2026 ET
- Resolution source
- Trading
- Closed
- In review
- Resolved
Rules text
If the FDA approves retatrutide (LY3437943) for marketing before Jan 1, 2028, then the market resolves to Yes.